Insider Trading May 5, 2026 07:28 PM

Ultra Clean Holdings Director Executes $2.26 Million Stock Sale Under Pre-Arranged Plan

Clarence L. Granger disposes of 30,000 shares as UCTT trades near annual highs following strong quarterly performance.

By Sofia Navarro UCTT

Clarence L. Granger, a director at Ultra Clean Holdings, Inc. (NASDAQ:UCTT), has completed the sale of 30,000 shares of common stock. The transaction, valued at approximately $2.26 million, was conducted through a Rule 10b5-1 trading plan established in late 2025. This move occurs amidst a period of significant share price appreciation for the semiconductor industry supplier, even as valuation assessments suggest potential overvaluation.

Ultra Clean Holdings Director Executes $2.26 Million Stock Sale Under Pre-Arranged Plan
UCTT

Key Points

  • Director Clarence L. Granger sold 30,000 shares totaling $2.26 million under a Rule 10b5-1 plan.
  • UCTT reported Q1 2026 earnings of $0.31 per share and revenue of $533.7 million, both beating estimates.
  • Analysts from Needham and UBS have issued bullish outlooks with price targets up to $130.

Clarence L. Granger, a member of the board of directors at Ultra Clean Holdings, Inc. (NASDAQ:UCTT), has finalized the sale of 30,000 shares of the company's common stock. The transactions took place on May 1, 2026, resulting in total proceeds of approximately $2.26 million. According to regulatory filings, the individual share prices for these sales fluctuated between $74.41 and $77.34.

The divestment was carried out under the framework of a pre-arranged Rule 10b5-1 trading plan. Mr. Granger had originally adopted this specific trading plan on November 7, 2025. This structured approach to selling allows insiders to execute trades at predetermined times or prices to avoid conflicts regarding non-public information.


Transaction Breakdown

The sale of the 30,000 shares was executed across several distinct tranches, each with varying weighted average prices and price ranges:

  • A tranche consisting of 12,523 shares was sold at a weighted average price of $74.41. The individual transaction prices within this group ranged from $73.95 to $74.93.
  • A second tranche of 11,302 shares was sold at a weighted average price of $75.46, with individual sales occurring between $75.00 and $75.93.
  • A third portion totaling 3,700 shares was sold at a weighted average price of $76.44. Prices for these specific transactions were recorded between $76.10 and $77.00.
  • The final tranche comprised 2,475 shares, sold at a weighted average price of $77.34, with individual prices ranging from $77.14 to $77.64.

Following the completion of these sales, Mr. Granger maintains a direct holding of 81,817 shares of Ultra Clean Holdings common stock. He also holds an indirect interest of 1,000 shares through a trust.


Market Context and Financial Performance

The timing of this insider activity coincides with a period of substantial growth for UCTT. The stock is currently trading at $83.14, which is near its 52-week high of $84.43. Over the previous year, the stock has seen a significant gain of 326%. However, analysis from InvestingPro suggests that the stock may be overvalued at these current levels when compared to its Fair Value.

Despite the insider selling, Ultra Clean Holdings recently reported robust financial results for the first quarter of 2026. The Hayward, California-based semiconductor equipment supplier outperformed analyst expectations on both the top and bottom lines. Reported earnings per share (EPS) were $0.31, which exceeded the anticipated $0.26 by 19.23%. Additionally, revenue for the quarter reached $533.7 million, surpassing the projected $525.28 million.

Investment analysts have reacted to these results with optimism regarding the company's fundamentals. Needham recently increased its price target for UCTT from $70 to $92 while maintaining a Buy rating, noting that non-GAAP gross margins and revenue were stronger than expected due to improved product mix and higher volumes. Furthermore, UBS initiated coverage on the company with a buy rating and a $130.00 price target, highlighting UCTT's role as a key supplier to major semiconductor equipment manufacturers such as Applied Materials and Lam Research.


Key Points

  • Insider Divestment via Automated Planning: The sale of 30,000 shares by Director Clarence L. Granger was conducted through a Rule 10b5-1 plan established in November 2025, providing a structured exit for a portion of his holdings.
  • Exceptional Stock Momentum: UCTT has experienced a 326% increase over the past year, trading near its 52-week high despite discussions regarding current valuation levels.
  • Strong Operational Fundamentals: The company's Q1 2026 results showed significant beats in both revenue and earnings per share, supported by strong gross margins.

Market Impact and Sector Implications

This activity primarily impacts the semiconductor manufacturing services sector. As a supplier to industry giants like Lam Research and Applied Materials, Ultra Clean Holdings' performance is a bellwether for the broader semiconductor equipment ecosystem. Positive earnings and analyst upgrades suggest continued demand in this specialized segment of the technology market.


Risks and Uncertainties

  • Valuation Discrepancies: There is an identified risk regarding whether the stock is overvalued relative to its Fair Value, which could lead to price corrections despite strong recent performance.
  • Market Volatility: While the company has seen massive gains (326% annually), such rapid appreciation can introduce volatility into the semiconductor equipment sector.

Risks

  • Potential overvaluation relative to Fair Value according to InvestingPro analysis.
  • Dependence on major semiconductor equipment makers like Lam Research and Applied Materials for market positioning.

More from Insider Trading

SentinelOne CEO Executes $3.55 Million Stock Sale Under Rule 10b5-1 Plan May 5, 2026 Axsome Therapeutics COO Executes $1.08 Million Stock Sale via Pre-Planned Trading Program May 5, 2026 Arcutis Biotherapeutics Director Executes Stock Sale via Pre-Arranged Plan May 5, 2026 Amgen Executive Nancy Grygiel Executes Recent Stock Transactions May 5, 2026 Privia Health CFO Executes Stock Sales Totaling Over $200,000 via Rule 10b5-1 Plan May 5, 2026